APOE and Alzheimer disease: Increased genetic risk of AD was a stronger predictor of adverse outcomes (higher odds of being an accumulator and earlier estimated AAO-Aβ) in ε4 non-carriers and heterozygotes than in ε4 homozygotes, suggesting it contributes little additional risk in individuals who are already at highest risk due to APOE ε4 homozygosity.